NCT01181908View on ClinicalTrials.gov

Alcohol Interaction Study

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

November 11, 2009

Primary Completion Date

December 30, 2009

Study Completion Date

December 30, 2009

Conditions

Alcoholism

Interventions

DRUG

single dose

Subjects will receive a single dose of GSK1144814 or placebo.

Trial Locations (1)

2333 CL

GSK Investigational Site, Leiden

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01181908 - Alcohol Interaction Study | Biotech Hunter | Biotech Hunter